Related Experiment Video
Updated: Jun 5, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Screening for prostate cancer: growth without control.
François Eisinger1, Jean-Yves Blay, Xavier Pivot
1Paoli-Calmettes Institute, Department of Anticipation and Follow-up of Cancer, Marseille, France. eisingerf@marseille.fnclcc.fr
Summary
Prostate cancer screening in France has significantly increased, with more men undergoing tests more frequently and at younger ages. General practitioners
Area of Science:
- Urology
- Public Health
- Epidemiology
Background:
- France lacks official guidelines for systematic prostate cancer screening.
- Individual choices and general practitioner (GP) recommendations currently guide screening decisions.
- Prostate cancer screening involves assessing risk and patient preference.
Purpose of the Study:
- To analyze trends in prostate cancer screening rates among men in France.
- To examine the influence of general practitioners on prostate cancer screening practices.
- To identify changes in screening behavior and age demographics over time.
Main Methods:
- Nationwide observational studies (surveys) conducted in France in 2005 and 2008.
- Representative samples of men aged 40-75 and general practitioners were surveyed.
- Data collected on screening status, frequency, and physician recommendations.
Main Results:
- Prostate cancer screening increased from 36% in 2005 to 49% in 2008 among men aged 50-75.
- Screening frequency increased, with 74% of screened men in 2008 reporting screening within the past year, up from 51% in 2005.
- GP recommendations for systematic screening rose from 58% in 2005 to 65% in 2008.
Conclusions:
- Significant rise in prostate cancer screening observed in France, with increased uptake, frequency, and earlier initiation.
- The typical age for initiating prostate cancer screening is around 50 years.
- Further research may be needed to establish official screening guidelines.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

